Sun Pharma Explores Funding Mix for $12 Billion Organon Deal

Sun Pharma is exploring funding options for its $12 billion deal to acquire Organon. The deal is a significant investment for Sun Pharma and requires careful consideration of funding sources. The company is weighing its options to secure the necessary funds.